secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001628280-26-005793
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD reorganizes into five segments; provides recast historical revenue data
--------------------------------------------------------------------------

- New segments effective Oct 1, 2025: Medical Essentials, Connected Care, BioPharma Systems, Interventional, Life Sciences.
- Life Sciences segment to be eliminated after planned combination of Biosciences/Diagnostic Solutions with Waters Corp (announced July 13, 2025).
- Exhibit 99.1 furnishes recast segment revenues for FY2025 and quarterly periods, including non-GAAP measures.
- Segment reorganization does not affect principal product lines of any organizational unit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000162828026005793/0001628280-26-005793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000162828026005793/bdx-20260205.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-005793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer